Skip Navigation

Faculty Directory

Daniel Salmon, PhD

Deputy Director, Institute for Vaccine Safety

Associate Professor

Departmental Affiliation(s):

International Health
Division: Global Disease Epidemiology and Control
Health, Behavior and Society (Joint)

Education

PhD , Bloomberg School of Public Health
MPH , Emory University Rollins School of Public Health

Overview

Dr. Salmon's primary research and practice interests are in optimizing the prevention of childhood infectious diseases through the use of vaccines. He has focused on post-licensure vaccine safety and the factors associated with parental decisions to vaccinate, or not vaccinate, their children. He has conducted studies examining the rates of vaccine refusal, the reasons why parents refuse vaccines, the impact of health care providers and local and state policies on vaccine refusal and the individual and community risks of unvaccinated children. Other interests and research include the financing and delivery of vaccines, vaccine risk communication, and issues surrounding mandatory immunizations.

 

Honors and Awards

 

Haddon Fellow, Johns Hopkins University Bloomberg School of Public Health (1999-2001)

 

Achievement Award – Dedication to Students, Johns Hopkins Bloomberg School of Public Health (2005)

 

Development of the Federal Immunization Safety Task Force, Assistant Secretary for Health (2008)

 

Federal monitoring of H1N1 vaccine safety, Assistant Secretary for Health (2010)

 

International Health, vaccine; immunization; vaccine safety; mandatory immunization

  • Yih KW, Lee GM, Lieu TA, Ball R, Kulldorff M, Rett M, Wahl PM, Walraven CNM, Platt R, Salmon DA. Pandemic 2009 H1N1 Vaccine Safety Surveillance by the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System in 2009-2010. Am J Epidemiol. 2012 May 11. [Epub ahead of print].

  • Vadaparampil ST, Kahn JA, Salmon D, Lee JH, Quinn GP, Roetzheim R, Bruder K, Malo TL, Proveaux T, Zhao X, Halsey N, Giuliano AR. Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine. 2011 Nov 3;29(47):8634-41. Epub 2011 Sep 14.

  • Salmon DA, Pavia A, Gellin B. From Sugar Cubes to Injections: Vaccine Safety throughout the Product Lifecycle. Introduction from Guest Editors. Pediatrics. 2011 May;127 Suppl 1:S1-4.

  • Salmon DA, Akhtar A, Mergler MJ, Vannice KS, Izurieta H, Ball R, Lee GM, Vellozzi C, Garman P, Cunningham F, Gellin B, Koh H, Lurie N, and the H1N1 Working Group of the Federal Immunization Safety Task Force. Immunization Safety Monitoring Systems for the 2009 H1N1 Monovalent Influenza Vaccination Program. Pediatrics. 2011 May;127 Suppl 1:S78-86.

  • Hussain H, Omer SB, Manganello JA, Kromm EE, Carter T, Kan L, Stokley S, Halsey NA, Salmon DA. Immunization Safety in United States Print Media, 1995-2005. Pediatrics. 2011 May;127 Suppl 1:S100-6.